21/45
2.3 / 5 stars
All 45 Win/Lose results and 75 gray no-data contests shown below
PLSE Roast Me summary
PULSE BIOSCIENCES, INC. (PLSE). Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
- 2026-Q2: Total return Win; Revenue growth No data; EPS growth No data.
- 2026-Q1: Total return Win; Revenue growth No data; EPS growth No data.
- 2025-Q4: Total return Lose; Revenue growth No data; EPS growth No data.
- 2025-Q3: Total return Win; Revenue growth No data; EPS growth No data.
Trailing 1 year (4 quarters): 3 wins, 1 losses, 8 no dataLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/1 |
WinPLSE / S&P 28.44% / 15.20% |
No dataPLSE / S&P / 15.00% |
No dataPLSE / S&P / 50.40% |
| 2026-Q11/1 |
WinPLSE / S&P 57.25% / -4.33% |
No dataPLSE / S&P / 11.30% |
No dataPLSE / S&P / 27.70% |
| 2025-Q40/1 |
LosePLSE / S&P -22.43% / 2.65% |
No dataPLSE / S&P / 9.00% |
No dataPLSE / S&P / 13.40% |
| 2025-Q31/1 |
WinPLSE / S&P 17.30% / 8.12% |
No dataPLSE / S&P / 4.61% |
No dataPLSE / S&P / 13.45% |
| 2025-Q20/1 |
LosePLSE / S&P -6.22% / 10.94% |
No dataPLSE / S&P / 4.83% |
No dataPLSE / S&P / 10.63% |
| 2025-Q10/1 |
LosePLSE / S&P -7.58% / -4.27% |
No dataPLSE / S&P / 4.98% |
No dataPLSE / S&P / 10.57% |
| 2024-Q40/1 |
LosePLSE / S&P -0.74% / 2.41% |
No dataPLSE / S&P / 5.25% |
No dataPLSE / S&P / 6.15% |
| 2024-Q31/1 |
WinPLSE / S&P 56.75% / 5.89% |
No dataPLSE / S&P / 5.89% |
No dataPLSE / S&P / 6.11% |
| 2024-Q21/1 |
WinPLSE / S&P 28.47% / 4.28% |
No dataPLSE / S&P / 5.38% |
No dataPLSE / S&P / 5.12% |
| 2024-Q10/2 |
LosePLSE / S&P -28.84% / 10.56% |
LosePLSE / S&P -100.00% / 5.71% |
No dataPLSE / S&P / 5.59% |
| 2023-Q41/2 |
WinPLSE / S&P 203.72% / 11.69% |
LosePLSE / S&P -100.00% / 6.81% |
No dataPLSE / S&P / 7.78% |
| 2023-Q30/2 |
LosePLSE / S&P -43.95% / -3.27% |
LosePLSE / S&P -100.58% / 7.52% |
No dataPLSE / S&P / -5.03% |
| 2023-Q21/2 |
WinPLSE / S&P 113.99% / 8.74% |
LosePLSE / S&P -100.42% / 9.50% |
No dataPLSE / S&P / -8.57% |
| 2023-Q11/1 |
WinPLSE / S&P 21.30% / 7.50% |
No dataPLSE / S&P / 10.77% |
No dataPLSE / S&P / -15.69% |
| 2022-Q41/2 |
WinPLSE / S&P 20.43% / 7.56% |
LosePLSE / S&P -50.63% / 11.88% |
No dataPLSE / S&P / -17.99% |
| 2022-Q31/1 |
WinPLSE / S&P 50.33% / -4.88% |
No dataPLSE / S&P / 13.47% |
No dataPLSE / S&P / -1.41% |
| 2022-Q20/1 |
LosePLSE / S&P -68.52% / -16.10% |
No dataPLSE / S&P / 13.71% |
No dataPLSE / S&P / 11.04% |
| 2022-Q10/1 |
LosePLSE / S&P -67.18% / -4.60% |
No dataPLSE / S&P / 15.97% |
No dataPLSE / S&P / 42.23% |
| 2021-Q40/1 |
LosePLSE / S&P -31.44% / 11.03% |
No dataPLSE / S&P / 15.00% |
No dataPLSE / S&P / 96.40% |
| 2021-Q31/1 |
WinPLSE / S&P 31.71% / 0.58% |
No dataPLSE / S&P / 10.77% |
No dataPLSE / S&P / 69.42% |
| 2021-Q20/1 |
LosePLSE / S&P -30.74% / 8.55% |
No dataPLSE / S&P / 6.58% |
No dataPLSE / S&P / 51.81% |
| 2021-Q10/1 |
LosePLSE / S&P -0.75% / 6.17% |
No dataPLSE / S&P / -1.06% |
No dataPLSE / S&P / 7.39% |
| 2020-Q41/1 |
WinPLSE / S&P 102.37% / 12.15% |
No dataPLSE / S&P / -3.72% |
No dataPLSE / S&P / -33.42% |
| 2020-Q31/1 |
WinPLSE / S&P 12.72% / 8.93% |
No dataPLSE / S&P / -2.04% |
No dataPLSE / S&P / -27.10% |
| 2020-Q21/1 |
WinPLSE / S&P 46.09% / 20.54% |
No dataPLSE / S&P / -0.46% |
No dataPLSE / S&P / -27.11% |
| 2020-Q10/1 |
LosePLSE / S&P -46.61% / -19.60% |
No dataPLSE / S&P / 3.47% |
No dataPLSE / S&P / -14.75% |
| 2019-Q40/1 |
LosePLSE / S&P -13.15% / 9.07% |
No dataPLSE / S&P / 5.36% |
No dataPLSE / S&P / 2.99% |
| 2019-Q31/1 |
WinPLSE / S&P 16.97% / 1.70% |
No dataPLSE / S&P / 5.02% |
No dataPLSE / S&P / 0.21% |
| 2019-Q20/1 |
LosePLSE / S&P -24.96% / 4.30% |
No dataPLSE / S&P / 6.64% |
No dataPLSE / S&P / 8.65% |
| 2019-Q11/1 |
WinPLSE / S&P 53.49% / 13.65% |
No dataPLSE / S&P / 8.12% |
No dataPLSE / S&P / 14.29% |
| 2018-Q40/1 |
LosePLSE / S&P -19.24% / -13.52% |
No dataPLSE / S&P / 9.05% |
No dataPLSE / S&P / 18.23% |
| 2018-Q30/1 |
LosePLSE / S&P -6.27% / 7.71% |
No dataPLSE / S&P / 10.21% |
No dataPLSE / S&P / 19.06% |
| 2018-Q21/1 |
WinPLSE / S&P 11.90% / 3.43% |
No dataPLSE / S&P / 9.03% |
No dataPLSE / S&P / 14.46% |
| 2018-Q10/1 |
LosePLSE / S&P -42.67% / -0.76% |
No dataPLSE / S&P / 7.68% |
No dataPLSE / S&P / 12.46% |
| 2017-Q41/1 |
WinPLSE / S&P 26.81% / 6.64% |
No dataPLSE / S&P / 7.03% |
No dataPLSE / S&P / 13.82% |
| 2017-Q30/1 |
LosePLSE / S&P -46.10% / 4.48% |
No dataPLSE / S&P / 5.68% |
No dataPLSE / S&P / 17.57% |
| 2017-Q21/1 |
WinPLSE / S&P 69.18% / 3.09% |
No dataPLSE / S&P / 4.83% |
No dataPLSE / S&P / 17.74% |
| 2017-Q11/1 |
WinPLSE / S&P 214.00% / 6.07% |
No dataPLSE / S&P / 3.67% |
No dataPLSE / S&P / 13.32% |
| 2016-Q40/1 |
LosePLSE / S&P 3.34% / 3.82% |
No dataPLSE / S&P / 2.09% |
No dataPLSE / S&P / 7.05% |
| 2016-Q31/1 |
WinPLSE / S&P 40.09% / 3.85% |
No dataPLSE / S&P / 0.20% |
No dataPLSE / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | PLSE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 205.80% | 20.78% |
| Annualized return | 205.80% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | PLSE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 86.50% | 83.14% |
| Annualized return | 13.28% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | PLSE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 852.32% | 319.30% |
| Annualized return | 25.28% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |